Clinical Trial Update: A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating capecitabine treatment in patients with head and neck neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Head and Neck Neoplasms | Phase 2 | Status: UNKNOWN